Ngā hua rapu - Lin, Ju-Sheng
- E whakaatu ana i te 1 - 10 hua o te 10
-
1
-
2
-
3
-
4
-
5
-
6
miR-30a-3p inhibits the proliferation of liver cancer cells by targeting DNMT3a through the PI3K/AKT signaling pathway mā Chen, Qiong, Gao, Yuan, Yu, Qin, Tang, Feng, Zhao, Pei-Wei, Luo, Su-Kun, Lin, Ju-Sheng, Mei, Hong
I whakaputaina 2020Text -
7
-
8
Anti-Epstein-Barr Virus (EBV) Activity of β-l-5-Iododioxolane Uracil Is Dependent on EBV Thymidine Kinase mā Kira, Toshihiko, Grill, Susan P., Dutschman, Ginger E., Lin, Ju-Sheng, Qu, Fucheng, Choi, Yongseok, Chu, Chung K., Cheng, Yung-Chi
I whakaputaina 2000Text -
9
The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma mā Zhao, Juan-Feng, Zhao, Qiu, Hu, Hui, Liao, Jia-Zhi, Lin, Ju-Sheng, Xia, Chao, Chang, Ying, Liu, Jing, Guo, An-Yuan, He, Xing-Xing
I whakaputaina 2018Text -
10
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma mā Xue, Hui-Ying, Liu, Yong, Liao, Jia-Zhi, Lin, Ju-Sheng, Li, Bin, Yuan, Wei-Gang, Lee, Robert J., Li, Lei, Xu, Chuan-Rui, He, Xing-Xing
I whakaputaina 2016Text